| 3. Specific Colonic
Diseases / G.K.
Turnbull |
page
352 |
3.1 Colon Polyps
and Cancer
Colon cancer is the second
most common cancer (after lung cancer) in men and women combined in
Canada. Unlike lung cancer, it has a high survival rate in patients
diagnosed before it has spread beyond the confines of the bowel wall.
Since it is a very common cancer, has a high survival rate with early
curative surgery and is poorly responsive to other forms of cancer
therapy, a high index of suspicion must be maintained in approaching
patients with symptoms of colonic dysfunction (Table
1), especially if they are over the age of 40, when the incidence
of colon cancer begins to rise. Increased colon cancer risk is also seen
in patients with ulcerative colitis, a history of female genital or breast
cancer, or a family history of colon cancer or adenoma (including familial
polyposis syndromes).
TABLE 1. Presenting
features of colon cancer
|
Abdominal pain, including
symptoms of bowel obstruction
Change in bowel habit
Abdominal complaints of recent onset
Abdominal mass
Iron deficiency anemia
Hypokalemia |
|
The Dukes’ classification
is used to stage colon cancer after surgical resection. It is based on the
pathological extent and invasion of the primary colonic tumor (adenocarcinoma)
at the time of resection (Table
2). Dukes’ A stage is adenocarcinoma confined to the mucosa and
submucosa; the cure rate for this stage of adenocarcinoma with surgery is
about 90%. Dukes’ B stage has two subdivisions: B1 for adenocarcinomas
that have invaded the muscularis propria, and B2 for tumors that have
invaded through to the circular longitudinal muscle although regional
lymph nodes are free of cancer. Dukes’ C stage is adenocarcinoma that
has spread to regional lymph nodes, and Dukes’ D stage is adenocarcinoma
that is metastatic to distant sites, usually the liver and beyond. Cure
rates with stage C and D adenocarcinoma of the colon are very low with
surgery; as well, both chemotherapy and radiotherapy have limited success,
reinforcing the need to make an early diagnosis. Table 2 also describes
the newer TNM colorectal adenocarcinoma staging system, which is similar
to the Dukes’ A–D staging system. The TNM staging system includes
stage 0 when the carcinoma is limited to the mucosa and is called “in
situ.”
TABLE
2. Colorectal adenocarcinoma staging
|
| Dukes'
stage |
TNM stage |
Tumor
invasion |
5-year
survival |
|
|
0 |
Mucosa |
100% |
| A |
I |
Submucosa
No lymph node or distant metastases |
90% |
| B |
II |
B1: Circular
muscle
B2: Longitudinal muscle
No lymph node or distant metastases |
70-75% |
| C |
III |
C1: 1-4 lymph
nodes positive
C2: > 4 lymph nodes positive |
45% |
| D |
IV |
Distant
metastases (e.g., liver) |
20% or less |
|
Early recognition is of the
utmost importance to try to identify early cancer at a curative stage.
Therefore, patients with intermittent symptoms are as important to
investigate as patients with persistent symptoms, and the story of
occasional blood in the stool in a patient over 40 years of age should not
be attributed to local anorectal disease without excluding a more proximal
lesion. Many patients may present with no gastrointestinal symptoms, but
rather an iron deficiency anemia due to chronic bleeding from the tumor.
Patients may not see blood in the stool or note a melena stool,
particularly when there is a right-sided colonic lesion. A change in bowel
habit, often with constipation alternating with diarrhea, may be the first
sign of obstructive symptoms from a colon cancer, and should never be
ignored in a patient over 40 years of age with a recent onset of these
symptoms. Some patients may present with primarily diarrhea if they have a
high output of mucus and fluid from the tumor; in this instance the tumor
may be a villous adenoma, and some patients may have hypokalemia due to
large amounts of potassium lost with the mucus secretion from the tumor.
Carcinoembryonic antigen (CEA)
is a tumor marker that has limited use in diagnosing colon cancer but is
often useful in following patients with colon cancer. A high CEA level
before surgery often suggests a poor prognosis with probable metastases.
CEA that does not fall to normal levels one month after surgery suggests
that all the cancer has not been resected. After this, regular monitoring
of CEA levels can identify patients with early recurrence. Sometimes a
search for metastases will discover a solitary lesion in the liver that
may be resected with the use of chemotherapy, which may lead to a cure of
the cancer.
| 3.1.1 POLYP-CARCINOMA SEQUENCE |
|
It is now agreed that the
majority of colon cancer patients have a colonic adenocarcinoma arising
from an adenomatous polyp. Polyps of 2 cm or greater have about 50%
incidence of cancer, compared to 1% in adenomas of 1 cm or less.
Adenomatous polyps are a premalignant condition, and their identification
and removal before becoming malignant prevents the development of colon
cancer. These polyps can arise anywhere in the colon, but (as is the case
for colon cancer) they are more frequently seen in the left colon. The
majority of polyps are completely asymptomatic, but the occurrence of
occult bleeding does increase as they grow. Unfortunately, however, polyps
can still be missed, even with occult blood testing of the stool, since
the blood loss may be intermittent.
Three histologic types of
adenomatous polyps occur: tubular, tubulovillous and villous. The
malignant potential is greatest in villous polyps (40%) and lowest in
tubular polyps (5%), with an intermediate risk in tubulovillous polyps
(22%). The malignant potential may also be described pathologically as the
degree of “dysplasia”: the more severe the dysplasia, the greater the
rate of malignancy. These tubular, tubulovillous and villous polyps can
often be completely removed by snare polypectomy at colonoscopy if they
are pedunculated on a stalk, but sessile polyps that carpet a wide area of
colonic mucosa (often villous polyps) can usually be completely removed
only by resection surgery. Since polyps precede cancer and removal of
polyps “cures” the cancer, it has been hoped that screening
colonoscopy may help reduce the incidence of cancer. Other polyps as well
may be present at the initial or index colonoscopy, and polyps and cancer
tend to recur. This sets the stage for the rationale for performing
follow-up surveillance colonoscopies (colon cancer surveillance program).
The best time interval for this surveillance is probably every three
years; longer intervals between surveillance colonoscopies may be safe but
have yet to be tested. The cost-effectiveness of screening all patients
over the age of 40 has not been proven, and until particular subgroups of
patients likely to have polyps are identifiable, routine colonoscopy
screening is not indicated.
Particular conditions have
been associated with an increased risk of colon cancer. The polyposis
syndromes of familial polyposis and Gardner’s syndrome are manifested by
early onset (usually before age 30) of innumerable colonic adenomatous
polyps that eventually and invariably lead to colon cancer (usually before
age 40). Since the colon has too many polyps to remove by endoscopy-guided
polypectomy these patients are referred at an early age for total
colectomy to remove the risk of colon cancer. After colectomy these
patients still need regular gastroscopic surveillance. Biopsies are taken
from the ampulla of Vater to look for adenomas that frequently occur in
the proximal duodenum around the ampulla, and also the stomach is examined
endoscopically for evidence of adenomas of the stomach. An experimental
approach at present is to do tests on blood monocytes looking for mutation
of the APC gene, which is the cause of this autosomal dominant disease.
There are other families (site-specific colorectal cancer, family cancer
syndrome) that have a high risk of colon cancer (autosomal dominant
inheritance), with more than two first-degree relatives having had colon
cancer. This disease is called hereditary nonpolyposis colorectal cancer (HNPCC).
It would be prudent to enter such patients into a colon cancer
surveillance program of colonoscopy and/or air contrast barium enema if
they have colonic polyps when screened at age 40. Female patients with
HNPCC also appear to have an increased risk of endometrial and ovarian
cancer.
Also at a high risk for
colon cancer are patients with chronic ulcerative colitis for more than 10
years; this risk also appears to be present in patients with Crohn’s
pancolitis. The patients at highest risk are those who have had total
colon involvement and those with left-sided disease, up to and including
the hepatic flexure; patients with proctosigmoiditis are at least risk –
probably not greater than the general population. Curiously, the risk of
cancer does not correlate with the degree of disease activity. Therefore,
patients with just one bout of proven subtotal ulcerative colitis would
have an increased risk of cancer after 10 years of disease, and the
younger the patient at the time of onset of his or her disease, the
greater the cumulative risk of cancer will be for that patient. Unlike
those who experience the “polyp–carcinoma sequence,” patients with
colitis do not develop adenomatous polyps before they develop cancer;
therefore they require colonoscopy about every one to two years, with
endoscopic biopsies of the colon performed to identify dysplasia of the
mucosa. Particular attention should be paid to “elevated” or
“flat” lesions seen at colonoscopy where the incidence of early colon
cancer is high. If there is dysplasia, either “high grade” or “low
grade,” colectomy should be recommended to the patient.
| 3.2 Diverticulosis |
page 356 |
In Western societies
diverticulosis occurs in at least one person in two over the age of 50
years. The frequency increases with age. Diverticulosis or diverticular
disease of the colon is due to pseudodiverticula in that the wall of the
diverticulum is not full-thickness colonic wall, but rather outpouchings
of colonic mucosa through points of weakness in the colonic wall where the
blood vessels penetrate the muscularis propria. These diverticula are
prone to infection or “diverticulitis” presumably because they trap
feces with bacteria. If the infection spreads beyond the confines of the
diverticula in the colonic wall, an abscess is formed. Patients present
with increasing left lower quadrant pain and fever, often with
constipation and lower abdominal obstructive symptoms such as bloating and
distention. Some patients with severe obstructive symptoms may actually
describe nausea or vomiting. This can occur with or without abscess
formation. Other causes of these symptoms include Crohn’s colitis with
stricture formation, colonic cancer and ischemic colitis (see Section
4).
On physical examination the
patient often has localized tenderness in the left lower quadrant, and
with severe infection and an abscess may have rebound tenderness in the
left lower quadrant. A palpable mass is often identifiable where the
sigmoid colon (the most common site of diverticulitis) is infected.
Treatment consists of intravenous fluids and bowel rest by placing the
patient on no oral intake or just a clear liquid diet; intravenous
antibiotics are administered. Generally broad-spectrum antibiotics are
used to cover both gram-negative enteric bacteria and anaerobic bacteria
that are normally found in the colon. CT scan may be helpful in outlining
the colon and identifying an abscess, and is preferable to barium enema
for diagnosis in patients with acute illness.
Many complications can
occur in diverticulitis. These are listed in Table
3. Colonic stricture after resolution of diverticulitis is
described further in Section 3.3.
TABLE 3.
Complications of diverticulitis
|
Abdominal abscess/Liver
abscess
Colonic obstruction
Fistulas
-Colovesical
-Colovaginal
-Colocutaneous |
|
Bleeding occurs in less
than 5% of diverticulosis patients; is abrupt in onset, painless, and
often massive. A bleeding diverticulum can be from either the left or
right colon. The bleeding frequency is approximately equal because of the
much higher frequency of left colonic diverticulosis, even though bleeding
is more likely to occur in right colonic diverticulosis. It is rare for
patients with diverticulosis to have significant bleeding. Over 80% of
diverticulosis patients will stop bleeding, but the rest will continue and
require investigation and treatment (see Section 5).
Segmental colonic resection is reserved for that small group of patients
who continue bleeding or have recurrent bleeding. Recent reports recommend
that patients under the age of 40 with symptomatic diverticulitis should
have surgical resection because this small subgroup is at greater risk of
complications.
| 3.3 Colonic Obstruction |
page 357 |
Acute colonic obstruction
is a surgical emergency that must be recognized early and dealt with
expeditiously in order to avoid the high fatality rate due to colonic
perforation. The highest risk patients for colonic perforation are those
with an intact ileocecal valve that does not allow air to reflux back into
the small bowel from the obstructed colon. The cecum is the most frequent
site of perforation, because wall tension is highest in the bowel with the
largest diameter (Laplace’s law).
Patients with colonic
obstruction usually have pain as a prominent symptom, with constipation
often preceding the complete obstruction. Patients may initially present
with diarrhea as the bowel distal to the obstruction empties, but diarrhea
may be persistent, especially with a partial obstruction, because of the
increased intestinal secretion proximal to the obstruction. The small
intestine is the most common site of intestinal obstruction because of the
narrower caliber of the bowel, and similarly the left colon is the most
common site for colonic obstruction, especially since the stool is more
formed in the left colon and unable to pass through a narrowed lumen.
On physical examination the
general state of the patient depends upon the duration of the obstruction.
With a recent sudden obstruction the patient will be in extreme pain, will
often have distention of the abdomen if the ileocecal valve is intact and
may describe initially diarrheal stool as the bowel distal to the
obstruction is emptied. Abdominal palpation can often discern a mass
lesion at the site of the obstruction. Prompt identification of the site
of obstruction is mandatory, with the use of supine and erect abdominal
x-rays. An urgent surgical consultation is required if the rectum is empty
of air with dilation of more proximal colon, indicating a complete colonic
obstruction.
Many patients may present
with a more gradual history. If they have had protracted diarrhea up to
the point of obstruction, the amount of abdominal pain may be less; they
may have abdominal distention, but be less tender on abdominal exam; and
they will often show signs of dehydration. Fever and an abdominal mass is
particularly common in patients with diverticulitis and a resulting
colonic obstruction. A third type of colonic obstruction can be seen that
is actually a form of ileus limited to the colon and is sometimes referred
to as Ogilvie’s syndrome. These patients are most often seen in
intensive care units, but the condition can also occur postoperatively
(even when no bowel surgery has been performed). As with a
“mechanical” bowel obstruction described above, patients with
Ogilvie’s syndrome may have marked abdominal distention, but frequently
they have little abdominal pain and the abdominal x-rays show a picture of
dilated colon with impaired movement of air into the distal colon.
Once a diagnosis of colonic
obstruction has been made, the site of obstruction should be determined by
plain abdominal x-rays and/or with a water-soluble contrast enema (such as
iothalamate meglumine) to identify whether urgent surgery is indicated.
Urgent colonoscopy is being done increasingly in this setting, especially
if a colonic ileus or Ogilvie’s syndrome is suggested, since the excess
colonic air can be aspirated via the colonoscope and colonic decompression
tubes can be placed in the colon to prevent dangerous reaccumulation of
air until the ileus resolves.
Some authorities dispute
the safety of colonoscopy in Ogilvie’s syndrome and recommend prokinetic
drugs instead. Unfortunately, drug therapy alone rarely works in severe
cases of Ogilvie’s syndrome, and if surgery is to be avoided the colon
must be decompressed endoscopically. A dual approach of both careful
colonoscopic decompression and prokinetic therapy may be best but is
untested in clinical trials.
There are many causes of
colonic obstruction (Table 4).
Colon cancer and diverticulitis are the most common causes. Most colon
cancers that obstruct are in the left colon. They cause circumferential
disease or “apple-core” lesions (so called because of the irregular
mucosal appearance with luminal narrowing seen at x-ray). Diverticulitis
commonly occurs in the sigmoid colon, where diverticular disease is most
common; the acute abscess formation with swelling of the inflamed
diverticulum compresses and obstructs the affected sigmoid colon.
Ogilvie’s syndrome may initially have been considered to be due to a
cancer or diverticulitis, but contrast x-ray or colonoscopy demonstrates a
patent lumen and the diagnosis appears to be clear.
TABLE 4. Causes of
colonic obstruction
|
Common
Left-sided cancer
Diverticulitis
Ogilvie's syndrome |
Others
Hernia
Strictures
-Crohn's
-Postischemic
-Postsurgical
Intussusception
Volvulus
Adhesions |
|
Less common causes of
colonic obstruction are hernias, in which a loop of colon (usually
sigmoid) becomes strangulated and the bowel is acutely obstructed. This is
a much more common cause of small bowel obstruction. Strictures in the
colon can also be associated with obstruction, especially when they occur
in the left colon. These can occur with Crohn’s colitis, after a bout of
ischemic colitis or at the site of anastomosis following colonic surgery.
This latter cause of obstruction should always be visualized
endoscopically if possible, since most colonic resections are for cancer
and the possibility of a local cancer recurrence can complicate a
postsurgical stricture.
Intussusception can occur
in the colon, and in adults it almost always occurs at the site of a
polyp, which “leads” the intussusception. Typically, this will cause
intermittent acute bowel obstruction associated with severe pain and often
rectal bleeding from the vascular compromise produced in the
intussuscepting bowel. Because of the intermittent nature of the
obstruction, a diagnosis may not made be until after repeated attacks. A
barium enema should always be considered in this setting, as it identifies
the mucosal lesion “leading” the intussusception and can occasionally
be used to reduce the intussusception without the need for urgent surgery.
Volvulus of the colon tends
to happen in the cecum and/or the sigmoid colon, because the mesentery can
be long and redundant in these areas and cause the bowel to rotate upon
itself. This can be a surgical emergency, since the affected bowel will
strangulate if the volvulus is not relieved quickly. Again, an urgent
barium enema may be able to reduce the volvulus, thus allowing a more
elective surgical procedure to correct the problem. A sigmoid volvulus
will usually be reduced by this approach, and success with colonoscopic
decompression of a sigmoid volvulus has been reported. A cecal volvulus
may not be easily treatable with either a barium enema or colonoscopic
therapy; thus, surgical advice should be sought urgently if cecal volvulus
is diagnosed.
Adhesions are often
described as a common cause of bowel obstruction, but this is probably
true only for small bowel obstruction. Since much of the colon is
retroperitoneal or on a limited mesentery, adhesive disease with
obstruction of the colon is rare. However, it can occur, particularly in
the sigmoid colon if the mesentery is quite long, and particularly after
pelvic operations.
| 3.4 Irritable Bowel Syndrome |
page 360 |
Most commonly, patients
exhibiting symptoms from the GI tract are suffering from the irritable
bowel syndrome. This is a condition that may be a variant of normal
function. Causes of irritable bowel are still being evaluated, but the
syndrome does sometimes occur after an episode of infectious diarrhea. It
appears that patients have no organic disease of the gastrointestinal
tract, yet they experience frequent symptoms from the bowel. Large
epidemiologic studies would suggest that the condition occurs in at least
15% of the population.
The commonest symptom that
brings a patient to a doctor is abdominal pain. Criteria have been
developed to identify with more certainty those patients who have the
irritable bowel syndrome. A more positive diagnosis can be made,
particularly in women, if the abdominal pain is not localized and tends to
have been present for at least three months. The pain is associated with
bowel movements and relieved after defecation. Abdominal pain is also
associated with increased looseness of stool as well as increased
frequency. For a “strict” diagnosis of the irritable bowel syndrome,
along with the above criteria it is felt that three of the following
symptoms should also be present: (1) patients have difficult defecation;
(2) patients complain of abdominal bloating or distention; (3) mucus is
present in the stool; (4) there is increased stool frequency; (5) there is
increased looseness of the stool at the onset of the abdominal pain.
Patients who have
difficulty with defecation can have the following complaints. There can be
“urgency,” with the sudden urge to pass stool and a fear of
incontinence if defecation is not performed immediately. Many patients
with this symptom will relate that they always identify where the toilet
is when they are away from home. The fear of incontinence can often
greatly limit a patient’s ability to function normally in society. Other
patients with difficult defecation may have to strain – defined as
having to hold their breath and push when attempting defecation. Straining
is defined as “constipation” when a patient must strain 25% or more of
the time when trying to defecate. Finally, some patients describe a
feeling of incomplete emptying after passing stool. This symptom has to be
asked for specifically, as most patients will not spontaneously report it.
Nevertheless, the symptom is commonly reported by patients with an
irritable bowel.
The presence of mucus in
the stool can be alarming to some patients, since they may interpret this
to mean they have “colitis.” In the past, some doctors used to refer
to irritable bowel as “mucus colitis,” which is a misnomer since there
is no “colitis” or inflammation of the colon in irritable bowel. Mucus
is a normal product of the colon, and only if mucus and blood are seen
together should other diagnoses such as “colitis” be considered.
The typical stool pattern
described by patients with an irritable bowel is the change in stool
character and frequency with the onset of abdominal pain. Typically,
patients will pass a normally formed stool (sometimes even a constipated
stool) first thing in the morning. Then with the attacks of abdominal pain
the stools become more frequent and looser, sometimes becoming just liquid
diarrheal stools. Once bowel movements cease the pain is relieved, but it
can recur again later in the day, often precipitated by eating high-fat
foods or other gut stimulants (e.g., coffee).
There have been reports
that in men the above criteria (called the Manning Criteria) may not be as
helpful as they are in women. It is also important to note that the vast
majority of people with an irritable bowel have their symptoms begin in
young adult life. One should consider other colonic diseases in patients
over the age of 40 who develop these symptoms for the first time without
previous episodes suggesting irritable bowel. Sometimes later in life
patients can develop irritable bowel after severe infectious diarrhea, but
in this population as well, further investigations are warranted to ensure
no other cause for the change in bowel function.
The irritable bowel
syndrome is a disorder affecting the entire gut, and although many of the
symptoms appear to arise from the colon, these patients frequently have
symptoms from other parts of the GI tract as well as from other organs.
Upper GI symptoms are very common in irritable bowel; these consist of
increased frequency of esophageal reflux. As well, nonulcer dyspepsia is
associated with irritable bowel. Dyspepsia symptoms in general occur more
commonly than lower bowel symptoms, but are obviously due to many other
causes, including reflux esophagitis, gastritis, peptic ulcer disease and,
less commonly, biliary tract and pancreatic disease. When upper GI
symptoms are associated with irritable bowel, other underlying diseases
must be considered. Other associated symptoms include frequent headaches
and urinary symptoms that are similar to bowel symptoms, in that patients
can have urgency and frequency of urination. These symptoms are often
worse at times when the bowel symptoms are troublesome. In women,
irritable bowel symptoms can often be exacerbated or worsened around the
time of menstruation. Studies suggest that bowel symptoms associated with
menstruation occur in at least 50% of the normal female population.
When assessing a patient
complaining of irritable bowel symptoms, remember that only a small
proportion of patients with an irritable bowel present to doctors with
these symptoms. Recent studies would suggest that patients who see doctors
about their symptoms often have psychological problems, with increased
levels of distress and depression as common findings. It is important to
inquire about these problems, as successful treatment often consists of
dealing with the distress and/or depression that accompanies the irritable
bowel symptoms. They may often be the reason that the patient has sought
medical attention in the first place.
| 3.4.1 DIFFERENTIAL DIAGNOSIS |
|
The Manning Criteria
provide a more positive diagnosis of irritable bowel: abdominal pain with
the association of increased frequency and increased looseness of stool,
relief of abdominal pain with defecation, abdominal bloating, mucus in the
stool and defecation difficulties such as a sensation of incomplete rectal
emptying after defecation. However, lactose intolerance is a common cause
of change in bowel habit in young adults, particularly if their racial
background is not northern European. Therefore, investigating for lactose
intolerance in patients who present with increased frequency and looseness
of stool is worthwhile, since the ingestion of lactose-containing foods
may be the reason for their symptoms. All patients should have a thorough
physical examination, looking for evidence of disease in other organ
systems such as the thyroid, which can present with a change in bowel
habit. Patients with an irritable bowel will often have pain over the
colon, particularly the sigmoid colon, on palpation. The identification of
an enlarged liver or spleen or other abdominal masses necessitates further
investigations. A barium enema is rarely required in a young healthy adult
with new onset of irritable bowel symptoms. However, a patient over the
age of 40 presenting with symptoms that may be irritable bowel yet of new
onset and without previous complaints would warrant at least a barium
enema and a sigmoidoscopic examination. The barium enema should also
evaluate the terminal ileum if there is pain on palpation in the right
lower quadrant. A complete blood count with platelet count should be done,
as an elevated platelet count is often a sensitive finding for underlying
inflammation and in the presence of bowel symptoms could mean the presence
of early inflammatory bowel disease. Crohn’s disease is more likely to
present this way than irritable bowel. The persistence of the abdominal
pain, even though lessened after bowel movements, would suggest possible
underlying inflammation of the gut rather than an irritable bowel.
Ulcerative colitis usually presents with rectal bleeding. Rectal bleeding
is not a symptom of irritable bowel and its cause must always be
investigated. Fever, weight loss and symptoms that wake a patient from
sleep, as opposed to early waking in the morning, are all symptoms that
should be further investigated.
The presence of nocturnal symptoms,
particularly with diarrhea waking the patient at night, is almost never
due to an irritable bowel. Occasionally patients with depression who have
early morning waking report this symptom, but in general further
investigations are indicated.
The therapeutic approach in
irritable bowel is as much reassurance as any specific therapies, as most
patients do not have any “disease.” It is most important to do a
thorough history and physical examination to ensure that the complaints
are not due to any underlying disease. Once this has been confirmed,
explain to the patient how the bowel can produce these symptoms and that
there is no cause for concern. Since patients presenting with irritable
bowel symptoms frequently have more distress and tend to be more prone to
seek medical attention for other minor medical conditions than other
patients (so-called illness behavior), these patients may require
considerable reassurance to convince them that they do not have serious
disease. Part of this reassurance will be provided by screening blood
tests such as a complete blood count with platelet count. Sigmoidoscopic
examination will rule out most underlying early inflammatory bowel disease
and any rectal pathology, particularly in patients complaining of
defecation difficulties or a sensation of being unable to empty the rectum
adequately. The stool should be analyzed for pathogens if diarrhea is
present. Following these initial screening tests emphasis should be placed
on the stresses present in the patient’s life. Evaluating the level of
stress and taking steps to correct it will often be helpful. Many
patients, particularly those who have symptoms of constipation, may be
helped with a high-fiber diet (see Section 3.6).
Drug treatment for irritable bowel is
generally discouraged. There is no single drug that treats all the varied
symptoms in irritable bowel, but occasional patients will continue to have
intractable symptomatology. In this situation selected medications for
specific symptoms may be helpful. Table
5 outlines some drugs that may be useful for specific symptoms.
Drug therapy for irritable bowel should always be restricted to short
periods during exacerbation of symptoms, and patients should be taken off
medications when well. As irritable bowel is a chronic condition and is
probably “normal” for these patients, the chronic use of medications
often reinforces the notion that they have a “disease.” Reassuring the
patient that there is no association between irritable bowel symptoms and
the development of more serious bowel disease such as colon cancer or
inflammatory bowel disease can often alleviate some of the unreasonable
yet very real concerns of many patients who present to doctors with these
symptoms.
TABLE
5. Drug therapy in irritable bowel syndrome
|
| Symptom |
Drug |
Dosage |
|
| Abdominal
pain |
Anticholinergics
|
0.125 mg sl q4h prn
10-20 mg po tid-qid before meals |
|
Calcium
antagonists
|
50-100 mg po tid before meals |
|
Antidepressants
|
10-25 mg po hs (increase by 10-25 mg increments every 5 to 7 days as
tolerated) |
|
Enteric
opioids
|
100-200 mg po tid before meals |
| Constipation |
High-fiber
diet |
>
30 g daily plus 2 L liquid daily |
|
Osmotic
laxatives
|
15-30 mL po bid-tid |
|
Prokinetic
agent
|
20 mg po bid-qid |
|
Other agents
|
200 µg po bid-qid before meals |
| Diarrhea |
Binding agent
(resin)
|
4 g po once to four times daily |
|
Antimotility
agents
|
2-4 mg po prn to a maximum daily dose
of 16 mg |
|
|
2.5 mg po qid
prn |
| Abdominal
bloating, 'gas' |
Simethicone |
<
qid prn |
|
Peppermint
oil,
enteric coated |
1 cap po qid prn |
|
motility
agents
|
10-20 mg po bid-qid
10-20 mg po qid |
CONTINUE
to see Part 2 of this subsection |
|